MIASTENIA GRAVIS. INDICAZIONI, SCOPI, MODALITA DEL TRATTAMENTO INTENSIVO

Translated title of the contribution: Myasthenia gravis. Indications, aims and role of intensive treatment

A. Braschi, A. Scherini, D. Carbonera, A. Mapelli, G. Bellinzona, F. Bobbio Pallavicini, R. Dionigi, A. Gasperi

Research output: Contribution to journalArticle

Abstract

Some recent views on pathophysiology of myasthenia gravis are presented. The authors explain the typical damage of myasthenia gravis, i.e. the progressively reduced muscular function on the basis of an autoimmune derangement affecting the motor-end plates. The most commonly used types of treatment, both medical (i.e. antiChE, A.C.T.H., steroids and immunodepressant drugs) and surgical (thymectomy) are reviewed. The very important role of intensive care for the treatment either of myasthenia gravis per se or of possible consequences of some drugs (A.C.T.H. steroids) is also stressed. Finally the authors present their results of their experience on 36 patients affected by myasthenia gravis and admitted to I.C.U. once (29 patients) or twice or more (7 patients). They describe some practical problems presented by patients during their stay in I.C.U.

Original languageItalian
Pages (from-to)871-881
Number of pages11
JournalMinerva Anestesiologica
Volume45
Issue number11
Publication statusPublished - 1979

Fingerprint

Myasthenia Gravis
Adrenocorticotropic Hormone
Steroids
Motor Endplate
Thymectomy
Therapeutics
Critical Care
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Anesthesiology and Pain Medicine

Cite this

Braschi, A., Scherini, A., Carbonera, D., Mapelli, A., Bellinzona, G., Bobbio Pallavicini, F., ... Gasperi, A. (1979). MIASTENIA GRAVIS. INDICAZIONI, SCOPI, MODALITA DEL TRATTAMENTO INTENSIVO. Minerva Anestesiologica, 45(11), 871-881.

MIASTENIA GRAVIS. INDICAZIONI, SCOPI, MODALITA DEL TRATTAMENTO INTENSIVO. / Braschi, A.; Scherini, A.; Carbonera, D.; Mapelli, A.; Bellinzona, G.; Bobbio Pallavicini, F.; Dionigi, R.; Gasperi, A.

In: Minerva Anestesiologica, Vol. 45, No. 11, 1979, p. 871-881.

Research output: Contribution to journalArticle

Braschi, A, Scherini, A, Carbonera, D, Mapelli, A, Bellinzona, G, Bobbio Pallavicini, F, Dionigi, R & Gasperi, A 1979, 'MIASTENIA GRAVIS. INDICAZIONI, SCOPI, MODALITA DEL TRATTAMENTO INTENSIVO', Minerva Anestesiologica, vol. 45, no. 11, pp. 871-881.
Braschi A, Scherini A, Carbonera D, Mapelli A, Bellinzona G, Bobbio Pallavicini F et al. MIASTENIA GRAVIS. INDICAZIONI, SCOPI, MODALITA DEL TRATTAMENTO INTENSIVO. Minerva Anestesiologica. 1979;45(11):871-881.
Braschi, A. ; Scherini, A. ; Carbonera, D. ; Mapelli, A. ; Bellinzona, G. ; Bobbio Pallavicini, F. ; Dionigi, R. ; Gasperi, A. / MIASTENIA GRAVIS. INDICAZIONI, SCOPI, MODALITA DEL TRATTAMENTO INTENSIVO. In: Minerva Anestesiologica. 1979 ; Vol. 45, No. 11. pp. 871-881.
@article{0d470c6cb28648e1b1aa51b904233a9e,
title = "MIASTENIA GRAVIS. INDICAZIONI, SCOPI, MODALITA DEL TRATTAMENTO INTENSIVO",
abstract = "Some recent views on pathophysiology of myasthenia gravis are presented. The authors explain the typical damage of myasthenia gravis, i.e. the progressively reduced muscular function on the basis of an autoimmune derangement affecting the motor-end plates. The most commonly used types of treatment, both medical (i.e. antiChE, A.C.T.H., steroids and immunodepressant drugs) and surgical (thymectomy) are reviewed. The very important role of intensive care for the treatment either of myasthenia gravis per se or of possible consequences of some drugs (A.C.T.H. steroids) is also stressed. Finally the authors present their results of their experience on 36 patients affected by myasthenia gravis and admitted to I.C.U. once (29 patients) or twice or more (7 patients). They describe some practical problems presented by patients during their stay in I.C.U.",
author = "A. Braschi and A. Scherini and D. Carbonera and A. Mapelli and G. Bellinzona and {Bobbio Pallavicini}, F. and R. Dionigi and A. Gasperi",
year = "1979",
language = "Italian",
volume = "45",
pages = "871--881",
journal = "Minerva Anestesiologica",
issn = "0375-9393",
publisher = "Edizioni Minerva Medica S.p.A.",
number = "11",

}

TY - JOUR

T1 - MIASTENIA GRAVIS. INDICAZIONI, SCOPI, MODALITA DEL TRATTAMENTO INTENSIVO

AU - Braschi, A.

AU - Scherini, A.

AU - Carbonera, D.

AU - Mapelli, A.

AU - Bellinzona, G.

AU - Bobbio Pallavicini, F.

AU - Dionigi, R.

AU - Gasperi, A.

PY - 1979

Y1 - 1979

N2 - Some recent views on pathophysiology of myasthenia gravis are presented. The authors explain the typical damage of myasthenia gravis, i.e. the progressively reduced muscular function on the basis of an autoimmune derangement affecting the motor-end plates. The most commonly used types of treatment, both medical (i.e. antiChE, A.C.T.H., steroids and immunodepressant drugs) and surgical (thymectomy) are reviewed. The very important role of intensive care for the treatment either of myasthenia gravis per se or of possible consequences of some drugs (A.C.T.H. steroids) is also stressed. Finally the authors present their results of their experience on 36 patients affected by myasthenia gravis and admitted to I.C.U. once (29 patients) or twice or more (7 patients). They describe some practical problems presented by patients during their stay in I.C.U.

AB - Some recent views on pathophysiology of myasthenia gravis are presented. The authors explain the typical damage of myasthenia gravis, i.e. the progressively reduced muscular function on the basis of an autoimmune derangement affecting the motor-end plates. The most commonly used types of treatment, both medical (i.e. antiChE, A.C.T.H., steroids and immunodepressant drugs) and surgical (thymectomy) are reviewed. The very important role of intensive care for the treatment either of myasthenia gravis per se or of possible consequences of some drugs (A.C.T.H. steroids) is also stressed. Finally the authors present their results of their experience on 36 patients affected by myasthenia gravis and admitted to I.C.U. once (29 patients) or twice or more (7 patients). They describe some practical problems presented by patients during their stay in I.C.U.

UR - http://www.scopus.com/inward/record.url?scp=0018619671&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0018619671&partnerID=8YFLogxK

M3 - Articolo

C2 - 548812

AN - SCOPUS:0018619671

VL - 45

SP - 871

EP - 881

JO - Minerva Anestesiologica

JF - Minerva Anestesiologica

SN - 0375-9393

IS - 11

ER -